{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T02:11:12Z","timestamp":1783649472172,"version":"3.55.0"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001502","name":"Department of Atomic Energy, Government of India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001502","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005031","name":"Bhabha Atomic Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005031","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"India Ministry of Science & Technology Department of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.phymed.2025.157689","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T17:29:36Z","timestamp":1765560576000},"page":"157689","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["First-in-human clinical trial of high-dose sodium copper chlorophyllin: Pharmacology and efficacy as a dual immunomodulatory\/antiviral agent"],"prefix":"10.1016","volume":"150","author":[{"given":"Raghavendra S.","family":"Patwardhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaigham Abbas","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Gota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Checker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babita","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharmendra K.","family":"Maurya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debojyoti","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Ramani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binita K","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaitashi","family":"Purohit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basavaraj S.","family":"Mathapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayati","family":"Mullick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapan K.","family":"Ghanty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudeep","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahendra","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivkumar","family":"Madki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Awasthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh K.","family":"Sandur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19\u201325","key":"10.1016\/j.phymed.2025.157689_bib0002","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1-2","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"issue":"15","key":"10.1016\/j.phymed.2025.157689_bib0003","doi-asserted-by":"crossref","DOI":"10.3390\/nu14153045","article-title":"Exploring the binding interaction of active compound of pineapple against foodborne bacteria and novel coronavirus (SARS-CoV-2) based on molecular docking and simulation studies","volume":"14","author":"Abuzinadah","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.phymed.2025.157689_bib93","doi-asserted-by":"crossref","unstructured":"Anantharaj A., Gujjar S., Kumar S., Verma N., Wangchuk J., Khan N.A., Panwar A., Kanakan A.A.V., Vasudevan J.S., Das A., Pandey A.K., Pandey R., Medigeshi G.R. (2020) Kinetics of Viral Load, Immunological Mediators and Characterization of a SARS-CoV-2 Isolate in Mild COVID-19 Patients during Acute Phase of Infection.","DOI":"10.1101\/2020.11.05.20226621"},{"key":"10.1016\/j.phymed.2025.157689_bib0001","unstructured":"21, U.F.a.D.A.C.-C.o.F.R.T., 2024. Listing of color additives exempt from certification, in: ADMINISTRATION, U.S.F.D. (Ed.). FDA, MD, USA."},{"issue":"1","key":"10.1016\/j.phymed.2025.157689_bib0004","doi-asserted-by":"crossref","first-page":"5921","DOI":"10.1038\/s41467-023-41159-z","article-title":"Comprehensive proteomics and meta-analysis of COVID-19 host response","volume":"14","author":"Babacic","year":"2023","journal-title":"Nat. Commun."},{"issue":"100086","key":"10.1016\/j.phymed.2025.157689_bib0005","article-title":"Therapeutics for COVID-19 and post COVID-19 complications: an update","volume":"3","author":"Basu","year":"2022","journal-title":"Curr. Res. Pharmacol. Drug Discov."},{"issue":"6","key":"10.1016\/j.phymed.2025.157689_bib0006","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1472-765X.2009.02744.x","article-title":"Effects of chlorophyllin on replication of poliovirus and bovine herpesvirus in vitro","volume":"49","author":"Benati","year":"2009","journal-title":"Lett Appl Microbiol"},{"issue":"1648","key":"10.1016\/j.phymed.2025.157689_bib0007","article-title":"Cytokine storm in COVID-19-immunopathological mechanisms, clinical considerations, and therapeutic approaches: the REPROGRAM Consortium position paper","volume":"11","author":"Bhaskar","year":"2020","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.phymed.2025.157689_bib0008","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1472-765X.2004.01556.x","article-title":"Chlorophyllin protects HEp-2 cells from nuclear fragmentation induced by poliovirus","volume":"39","author":"Botelho","year":"2004","journal-title":"Lett Appl Microbiol"},{"key":"10.1016\/j.phymed.2025.157689_bib0009","unstructured":"Bowers, W.F., Chlorophyll in wound healing and suppurative disease. 0002-9610 (2025)."},{"key":"10.1016\/j.phymed.2025.157689_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127775","article-title":"Rationalizing recommendations for influenza and COVID-19 vaccines","volume":"65","author":"Breznik","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.phymed.2025.157689_bib0011","doi-asserted-by":"crossref","DOI":"10.1007\/s00210-025-03929-y","article-title":"The effect of the combination therapy with chlorophyllin, a glutathione transferase P1-1 inhibitor, and docetaxel on triple-negative breast cancer invasion and metastasis in vivo\/in vitro","author":"Burus","year":"2025","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.phymed.2025.157689_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.105788","article-title":"In-silico screening and in-vitro assay show the antiviral effect of Indomethacin against SARS-CoV-2","volume":"147","author":"Chakraborty","year":"2022","journal-title":"Comput Biol Med"},{"issue":"9","key":"10.1016\/j.phymed.2025.157689_bib0013","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1093\/cid\/ciaa325","article-title":"Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility","volume":"71","author":"Chan","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.phymed.2025.157689_bib0014","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-025-09332-0","article-title":"Respiratory viral infections awaken metastatic breast cancer cells in lungs","author":"Chia","year":"2025","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.phymed.2025.157689_bib0015","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.3346\/jkms.2024.39.e134","article-title":"Review of COVID-19 therapeutics by mechanism: from discovery to approval","volume":"39","author":"Choi","year":"2024","journal-title":"J. Korean Med. Sci."},{"issue":"27","key":"10.1016\/j.phymed.2025.157689_bib0016","first-page":"1753","article-title":"Str\\370msted H, Stenderup JK, Eickhoff JH. Nedsaetter klorofyl kolostomiopererede patienters lugtgener? [Can chlorophyll reduce fecal odor in colostomy patients?]","volume":"151","author":"Christiansen","year":"1989","journal-title":"Ugeskr Laeger."},{"issue":"6","key":"10.1016\/j.phymed.2025.157689_bib0017","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1021\/acsomega.2c03881","article-title":"Novel investigational anti-SARS-CoV-2 agent Ensitrelvir \u201cS-217622\u201d: a very promising potential universal broad-spectrum antiviral at the therapeutic frontline of coronavirus species","volume":"8","author":"Eltayb","year":"2023","journal-title":"ACS Omega"},{"issue":"14","key":"10.1016\/j.phymed.2025.157689_bib0018","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411565","article-title":"Anti-Cancer Effect of Chlorophyllin-Assisted Photodynamic Therapy to Induce Apoptosis through Oxidative Stress on Human Cervical Cancer","volume":"24","author":"Heo","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.phymed.2025.157689_bib89","doi-asserted-by":"crossref","unstructured":"Hingankar N, Deshpande S, Das P, Rizvi ZA, Wibmer CK, Mashilo P, Ansari MY, Burns A, Barman S, Zhao F, Mukherjee S, Torres JL, Chattopadhyay S, Mehdi F, Sutar J, Rathore DK, Pargai K, Singh J, Sonar S, Jakhar K, Dandotiya J, Bhattacharya S, Mani S, Samal S, Singh S, Kshetrapal P, Thiruvengadam R, Batra G, Medigeshi G, Ward AB, Bhatnagar S, Awasthi A, Sok D, Bhattacharya J. 2022. A combination of potently neutralizing monoclonal antibodies isolated from an Indian convalescent donor protects against the SARS-CoV-2 Delta variant. Plos Pathogen. 28;18(4):e1010465. doi:10.1371\/journal.ppat.10104656.","DOI":"10.1371\/journal.ppat.1010465"},{"issue":"3","key":"10.1016\/j.phymed.2025.157689_bib0020","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1002\/mco2.151","article-title":"The SARS-CoV-2 main protease (Mpro): structure, function, and emerging therapies for COVID-19","volume":"3","author":"Hu","year":"2022","journal-title":"MedComm"},{"issue":"1","key":"10.1016\/j.phymed.2025.157689_bib0021","first-page":"61","article-title":"In Vitro Inhibition of Cytopathic Effect of Influenza Virus and Human Immunodeficiency Virus by Bamboo Leaf Extract Solution and Sodium Copper Chlorophyllin","volume":"59","author":"Ito","year":"2016","journal-title":"Yonago Acta Med"},{"issue":"4","key":"10.1016\/j.phymed.2025.157689_bib0022","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jtcms.2021.10.001","article-title":"Therapeutic potential of ginger against COVID-19: Is there enough evidence?","volume":"8","author":"Jafarzadeh","year":"2021","journal-title":"Journal of Traditional Chinese Medical Sciences"},{"key":"10.1016\/j.phymed.2025.157689_bib85","doi-asserted-by":"crossref","unstructured":"Jyotsna D, Adhikari N, Tripathy MR, Jakhar K, Sonar S, Pati DR, Kanchan V, Prasad VS, Kumar J, Senapati NK, Bharmoria A, Rani N, Lakhanpal M, Patil CS, Singh N, Khan L, Jambu L, Jain NK, Ali SK, Priyadarsiny P, Panda AK, Jain R, Mani S, Samal S, Awasthi A, Rizvi ZA*. 2025. CoviWall, a whole-virion-inactivated B.1.617.2 vaccine candidate, induces potent humoral and Th1 cell response in mice and protects against B.1.617.2 strain challenge in Syrian hamsters. Front Immunol. 15. doi:10.3389\/fimmu.2024.1447962.","DOI":"10.3389\/fimmu.2024.1447962"},{"issue":"5","key":"10.1016\/j.phymed.2025.157689_bib0023","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/10715760100301571","article-title":"Scavenging of reactive oxygen species by chlorophyllin: an ESR study","volume":"35","author":"Kumar","year":"2001","journal-title":"Free Radic Res"},{"issue":"2","key":"10.1016\/j.phymed.2025.157689_bib0024","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bbagen.2004.03.002","article-title":"Effect of chlorophyllin against oxidative stress in splenic lymphocytes in vitro and in vivo","volume":"1672","author":"Kumar","year":"2004","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"10.1016\/j.phymed.2025.157689_bib0025","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1021\/acsinfecdis.0c00096","article-title":"Sodium copper chlorophyllin is highly effective against enterovirus (EV) A71 infection by blocking its entry into the host cell","volume":"6","author":"Liu","year":"2020","journal-title":"ACS Infect. Dis."},{"issue":"11","key":"10.1016\/j.phymed.2025.157689_bib0027","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24119589","article-title":"COVID-19 therapeutic potential of natural products","volume":"24","author":"Low","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.phymed.2025.157689_bib0028","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13732","article-title":"Molnupiravir: mechanism of action, clinical, and translational science","volume":"17","author":"Maas","year":"2024","journal-title":"Clin. Transl. Sci."},{"issue":"1498445","key":"10.1016\/j.phymed.2025.157689_bib0029","article-title":"COVID-19 clinical presentation, management, and epidemiology: a concise compendium","volume":"13","author":"Maison","year":"2025","journal-title":"Front. Public Health"},{"issue":"6","key":"10.1016\/j.phymed.2025.157689_bib0030","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41579-023-00878-2","article-title":"The evolution of SARS-CoV-2","volume":"21","author":"Markov","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"issue":"20499361251321724","key":"10.1016\/j.phymed.2025.157689_bib0031","article-title":"Ensitrelvir as a novel treatment option for mild-to-moderate COVID-19: a narrative literature review","volume":"12","author":"Mukae","year":"2025","journal-title":"Ther. Adv. Infect. Dis."},{"issue":"4","key":"10.1016\/j.phymed.2025.157689_bib0032","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","article-title":"Post-acute COVID-19 syndrome","volume":"27","author":"Nalbandian","year":"2021","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.phymed.2025.157689_bib0033","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.mrgentox.2003.10.012","article-title":"Anticlastogenicity of chlorophyllin in the different cell cycle phases in cultured mammalian cells","volume":"557","author":"Negraes","year":"2004","journal-title":"Mutat Res"},{"issue":"2","key":"10.1016\/j.phymed.2025.157689_bib0034","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0165-7992(86)90086-2","article-title":"Chlorophyllin: a potent antimutagen against environmental and dietary complex mixtures","volume":"173","author":"Ong","year":"1986","journal-title":"Mutat Res"},{"key":"10.1016\/j.phymed.2025.157689_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115491","article-title":"The research progress of SARS-CoV-2 main protease inhibitors from 2020 to 2022","volume":"257","author":"Pang","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.phymed.2025.157689_bib0036","unstructured":"Prevention, U.S.C.f.D.C.a., 2025. Types of COVID-19 treatment. USA.GOV, https:\/\/www.cdc.gov\/covid\/treatment\/index.html."},{"issue":"6","key":"10.1016\/j.phymed.2025.157689_bib0050","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1021\/acsbiomedchemau.2c00039","article-title":"Forodesine and riboprine exhibit strong anti-SARS-CoV-2 repurposing potential: in silico and in vitro studies","volume":"2","author":"Rabie","year":"2022","journal-title":"ACS Bio Med. Chem. Au"},{"issue":"46","key":"10.1016\/j.phymed.2025.157689_bib0051","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202201912","article-title":"A series of adenosine analogs as the first efficacious anti-SARS-CoV-2 drugs against the B.1.1.529.4 lineage: a preclinical repurposing research study","volume":"7","author":"Rabie","year":"2022","journal-title":"ChemistrySelect"},{"issue":"2","key":"10.1016\/j.phymed.2025.157689_bib0052","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s00044-022-02970-3","article-title":"Evaluation of a series of nucleoside analogs as effective anticoronaviral-2 drugs against the Omicron-B.1.1.529\/BA.2 subvariant: a repurposing research study","volume":"32","author":"Rabie","year":"2023","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.phymed.2025.157689_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.arres.2023.100064","article-title":"Strong dual antipolymerase\/antiexonuclease actions of some aminothiadiazole antioxidants: a promising in-silico\/in-vitro repurposing research study against the COVID-19 omicron virus (B.1.1.529.3 Lineage)","author":"Rabie","year":"2023","journal-title":"Adv. Redox Res."},{"issue":"4","key":"10.1016\/j.phymed.2025.157689_bib0054","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s12033-022-00551-8","article-title":"Potent dual polymerase\/exonuclease inhibitory activities of antioxidant aminothiadiazoles against the COVID-19 Omicron virus: a promising in silico\/in vitro repositioning research study","volume":"66","author":"Rabie","year":"2024","journal-title":"Mol. Biotechnol."},{"issue":"100214","key":"10.1016\/j.phymed.2025.157689_bib0056","article-title":"The isoquinoline derivative \u201cCYNOVID\u201d as a prospective anti-SARS-CoV-2 agent: an expanded investigative computational study","volume":"12","author":"Rabie","year":"2024","journal-title":"Eur. J. Med. Chem. Rep."},{"issue":"108454","key":"10.1016\/j.phymed.2025.157689_bib0055","article-title":"Targeting conserved regions of the SARS-CoV-2 polymerase (RdRp) with kinase inhibitors as an effective new tactic for discovering dual-action \u201cantiviral-antiinflammatory\u201d drugs against COVID-19","volume":"119","author":"Rabie","year":"2025","journal-title":"Comput. Biol. Chem."},{"issue":"131106","key":"10.1016\/j.phymed.2025.157689_bib0039","article-title":"Discovery of Taroxaz-104: the first potent antidote of SARS-CoV-2 VOC-202012\/01 strain","volume":"1246","author":"Rabie","year":"2021","journal-title":"J. Mol. Struct."},{"issue":"109480","key":"10.1016\/j.phymed.2025.157689_bib0040","article-title":"Potent toxic effects of Taroxaz-104 on the replication of SARS-CoV-2 particles","volume":"343","author":"Rabie","year":"2021","journal-title":"Chem. Biol. Interact."},{"issue":"100055","key":"10.1016\/j.phymed.2025.157689_bib0041","article-title":"Teriflunomide: a possible effective drug for the comprehensive treatment of COVID-19","volume":"2","author":"Rabie","year":"2021","journal-title":"Curr. Res. Pharmacol. Drug Discov."},{"issue":"2","key":"10.1016\/j.phymed.2025.157689_bib0042","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1039\/D0NJ03708G","article-title":"Two antioxidant 2,5-disubstituted-1,3,4-oxadiazoles (CoViTris2020 and ChloViD2020): successful repurposing against COVID-19 as the first potent multitarget anti-SARS-CoV-2 drugs","volume":"45","author":"Rabie","year":"2021","journal-title":"New J. Chem."},{"issue":"25","key":"10.1016\/j.phymed.2025.157689_bib0043","doi-asserted-by":"crossref","first-page":"21385","DOI":"10.1021\/acsomega.1c07095","article-title":"Efficacious preclinical repurposing of the nucleoside analogue didanosine against COVID-19 polymerase and exonuclease","volume":"7","author":"Rabie","year":"2022","journal-title":"ACS Omega"},{"issue":"1","key":"10.1016\/j.phymed.2025.157689_bib0044","first-page":"1","article-title":"Exploration of the potent toxic intracellular effects of the natural adenosine analog cordycepin against SARS-CoV-2 replication","volume":"1","author":"Rabie","year":"2022","journal-title":"J. Mod. Biol. Drug Discov."},{"issue":"4","key":"10.1016\/j.phymed.2025.157689_bib0045","doi-asserted-by":"crossref","first-page":"69","DOI":"10.37358\/RC.22.4.8555","article-title":"Improved synthesis of the Anti-SARS-CoV-2 investigational agent (E)-N-(4-Cyanobenzylidene)-6-fluoro-3-hydroxypyrazine-2-carboxamide (Cyanorona-20)","volume":"73","author":"Rabie","year":"2022","journal-title":"Rev. Chim."},{"issue":"2","key":"10.1016\/j.phymed.2025.157689_bib0046","first-page":"58","article-title":"The informative nature of the disappeared SARS-CoV-2 genomic sequences: a mini-review with perspectives","volume":"1","author":"Rabie","year":"2022","journal-title":"Adv. Chemicobiol. Res."},{"issue":"3","key":"10.1016\/j.phymed.2025.157689_bib0047","first-page":"225","article-title":"New potential inhibitors of coronaviral main protease (CoV-Mpro): strychnine bush, pineapple, and ginger could be natural enemies of COVID-19","volume":"9","author":"Rabie","year":"2022","journal-title":"Int. J. New Chem."},{"issue":"3","key":"10.1016\/j.phymed.2025.157689_bib0048","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1021\/acsomega.1c05998","article-title":"Potent inhibitory activities of the adenosine analogue cordycepin on SARS-CoV-2 replication","volume":"7","author":"Rabie","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.phymed.2025.157689_bib0037","doi-asserted-by":"crossref","unstructured":"Rabie, A.M., 2023. Future of the current anticoronaviral agents: a viewpoint on the validation for the next COVIDs and pandemics. 47(10), 2133\u20132139.","DOI":"10.32604\/biocell.2023.030057"},{"key":"10.1016\/j.phymed.2025.157689_bib0049","doi-asserted-by":"crossref","unstructured":"Rabie, A.M., 2024. RNA: the most attractive target in recent viral diseases. 103(1), e14404.","DOI":"10.1111\/cbdd.14404"},{"key":"10.1016\/j.phymed.2025.157689_bib0038","doi-asserted-by":"crossref","unstructured":"Rabie, A.A.O.X., Revolutionizing playing with skeleton atoms: molecular editing surgery in medicinal chemistry. 1875\u20135607 (2025).","DOI":"10.2174\/0113895575316229240611113946"},{"key":"10.1016\/j.phymed.2025.157689_bib0057","doi-asserted-by":"crossref","DOI":"10.1007\/s00210-025-04112-z","article-title":"Preclinical evaluation of sodium copper chlorophyllin: safety, pharmacokinetics, and therapeutic potential in breast cancer chemotherapy and cyclophosphamide-induced bladder toxicity","author":"Ramani","year":"2025","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"issue":"3","key":"10.1016\/j.phymed.2025.157689_bib0058","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/1348-0421.12133","article-title":"Antiviral activity of extracts from Morinda citrifolia leaves and chlorophyll catabolites, pheophorbide a and pyropheophorbide a, against hepatitis C virus","volume":"58","author":"Ratnoglik","year":"2014","journal-title":"Microbiol. Immunol."},{"issue":"1","key":"10.1016\/j.phymed.2025.157689_bib0059","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s10020-025-01180-y","article-title":"Chlorophyllin exerts synergistic anti-tumor effect with gemcitabine in pancreatic cancer by inducing cuproptosis","volume":"31","author":"Ren","year":"2025","journal-title":"Mol. Med."},{"key":"10.1016\/j.phymed.2025.157689_bib90","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.73522","article-title":"Golden Syrian hamster as a model to study cardiovascular complications associated with SARS-CoV-2 infection","volume":"11","author":"Rizvi","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.phymed.2025.157689_bib92","doi-asserted-by":"crossref","unstructured":"Rizvi ZA, Dalal R, Sadhu S, Kumar Y, Kumar S, Gupta SK, Tripathy MR, Rathore DK, Awasthi A. 2021. High dietary salt mediates interplay between NK cells and gut microbiota to induce potent tumor immunity. Science Advances. 7 (37): eabg5016. doi:10.1126\/sciadv.abg5016.","DOI":"10.1126\/sciadv.abg5016"},{"key":"10.1016\/j.phymed.2025.157689_bib91","doi-asserted-by":"crossref","unstructured":"Rizvi Z.A., Babele P., Sadhu S., Madan U., Tripathy M.R., Goswami S., Mani S., Kumar S., Awasthi A., Dikshit M. Prophylactic treatment of Glycyrrhiza glabra mitigates COVID-19 pathology through inhibition of pro-inflammatory cytokines in the hamster model and NETosis. Front Immunol. 2022 Sep 27;13:945583. doi:10.3389\/fimmu.2022.945583. PMID: 36238303; PMCID: PMC9550929.","DOI":"10.3389\/fimmu.2022.945583"},{"issue":"9","key":"10.1016\/j.phymed.2025.157689_bib88","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.3390\/ph16091333","article-title":"Evaluation of pharmacological potential of Ayush-64 formulation against COVID-19 and T cell differentiation","volume":"16","author":"Rizvi","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"7","key":"10.1016\/j.phymed.2025.157689_bib86","doi-asserted-by":"crossref","DOI":"10.1002\/eji.202350624","article-title":"SARS-CoV-2 infection induces thymic atrophy mediated by IFN-\u03b3 in hACE2 transgenic mice","volume":"54","author":"Rizvi","year":"2024","journal-title":"Eur J Immunol"},{"issue":"5","key":"10.1016\/j.phymed.2025.157689_bib87","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4103\/jdras.jdras_163_23","article-title":"The potential use of medicinal plant extracts\/products in the prevention of SARS-CoV2 infection and associated pathologies in the experimental models","volume":"9","author":"Rizvi","year":"2024","journal-title":"J of Drug Res in Ayurvedic Sci"},{"issue":"4","key":"10.1016\/j.phymed.2025.157689_bib0064","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines13040424","article-title":"Beyond the pandemic era: recent advances and efficacy of SARS-CoV-2 vaccines against emerging variants of concern","volume":"13","author":"Saha","year":"2025","journal-title":"Vaccines"},{"issue":"11","key":"10.1016\/j.phymed.2025.157689_bib0065","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1016\/j.molimm.2007.01.021","article-title":"Differential modulation of mitogen driven proliferation and homeostasis driven proliferation of T cells by rapamycin, Ly294002 and chlorophyllin","volume":"44","author":"Sharma","year":"2007","journal-title":"Mol Immunol"},{"issue":"4","key":"10.1016\/j.phymed.2025.157689_bib0066","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.molimm.2006.02.031","article-title":"Antiapoptotic and immunomodulatory effects of chlorophyllin","volume":"44","author":"Sharma","year":"2007","journal-title":"Mol Immunol"},{"key":"10.1016\/j.phymed.2025.157689_bib0067","article-title":"An observational multi-centric COVID-19 sequelae study among health care workers","volume":"10","author":"Shukla","year":"2023","journal-title":"Lancet Reg. Health Southeast Asia"},{"issue":"7818","key":"10.1016\/j.phymed.2025.157689_bib0068","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41586-020-2342-5","article-title":"Pathogenesis and transmission of SARS-CoV-2 in golden hamsters","volume":"583","author":"Sia","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.phymed.2025.157689_bib0069","unstructured":"Sigler M.L., Stephens, T.J., Assessment of the safety and efficacy of topical copper chlorophyllin in women with photodamaged facial skin. 1545-9616 (2025)."},{"issue":"3","key":"10.1016\/j.phymed.2025.157689_bib0070","article-title":"Antiviral agents for the treatment of COVID-19: progress and challenges","volume":"3","author":"Singh","year":"2022","journal-title":"Cell Rep. Med."},{"issue":"6","key":"10.1016\/j.phymed.2025.157689_bib0071","first-page":"589","article-title":"Pilot Study of Topical Copper Chlorophyllin Complex in Subjects With Facial Acne and Large Pores","volume":"14","author":"Stephens","year":"2015","journal-title":"J Drugs Dermatol"},{"issue":"101279","key":"10.1016\/j.phymed.2025.157689_bib0072","article-title":"Nucleoside analogs for management of respiratory virus infections: mechanism of action and clinical efficacy","volume":"57","author":"Stevaert","year":"2022","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.phymed.2025.157689_bib0073","doi-asserted-by":"crossref","unstructured":"Subong, B.J.J., Forteza, I.L., 2025. SARS-CoV-2 replication revisited: molecular insights and current and emerging antiviral strategies. 5(6), 85.","DOI":"10.3390\/covid5060085"},{"issue":"11","key":"10.1016\/j.phymed.2025.157689_bib0076","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1007\/s00210-020-01912-3","article-title":"Sodium copper chlorophyllin attenuates adenine-induced chronic kidney disease via suppression of TGF-beta and inflammatory cytokines","volume":"393","author":"Suryavanshi","year":"2020","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"56\u201370","key":"10.1016\/j.phymed.2025.157689_bib0075","article-title":"Amelioration of radiation-induced hematopoietic syndrome by an antioxidant chlorophyllin through increased stem cell activity and modulation of hematopoiesis","volume":"85","author":"Suryavanshi","year":"2015","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.phymed.2025.157689_bib0077","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1186\/s12906-025-05094-4","article-title":"Inhibitory effect of [6]-shogaol against 3CLpro activity and SARS-CoV-2 infection","volume":"25","author":"Tanikawa","year":"2025","journal-title":"BMC Complement. Med. Ther."},{"issue":"2","key":"10.1016\/j.phymed.2025.157689_bib0078","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.foodres.2011.10.031","article-title":"Copper chlorophyllin: a food colorant with bioactive properties?","volume":"46","author":"Tumolo","year":"2012","journal-title":"Food Res. Int."},{"issue":"4385\u20134394","key":"10.1016\/j.phymed.2025.157689_bib0079","article-title":"Current understanding of nucleoside analogs inhibiting the SARS-CoV-2 RNA-dependent RNA polymerase","volume":"21","author":"Xu","year":"2023","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"6","key":"10.1016\/j.phymed.2025.157689_bib0080","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28062735","article-title":"A comprehensive review of natural flavonoids with anti-SARS-CoV-2 activity","volume":"28","author":"Yang","year":"2023","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.phymed.2025.157689_bib0081","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1532-5415.1980.tb00124.x","article-title":"Use of chlorophyllin in the care of geriatric patients","volume":"28","author":"Young","year":"1980","journal-title":"J Am Geriatr Soc"},{"issue":"4","key":"10.1016\/j.phymed.2025.157689_bib0082","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01556-24","article-title":"Potent antiviral activity of simnotrelvir against key epidemic SARS-CoV-2 variants with a high resistance barrier","volume":"69","author":"Zhao","year":"2025","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.phymed.2025.157689_bib0083","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1186\/s40001-024-02220-9","article-title":"Azvudine efficacy in reducing mortality in COVID-19 patients","volume":"29","author":"Zhong","year":"2024","journal-title":"Eur. J. Med. Res."},{"issue":"10","key":"10.1016\/j.phymed.2025.157689_bib0084","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1177\/2472555220942123","article-title":"RNA-dependent RNA polymerase as a target for COVID-19 drug discovery","volume":"25","author":"Zhu","year":"2020","journal-title":"SLAS Discov."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325013248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325013248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T17:21:03Z","timestamp":1773940863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711325013248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":86,"alternative-id":["S0944711325013248"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2025.157689","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First-in-human clinical trial of high-dose sodium copper chlorophyllin: Pharmacology and efficacy as a dual immunomodulatory\/antiviral agent","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2025.157689","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"157689"}}